Translation Research _ J Laboratory _ clinical med Collection home page

Browse
Subscribe to this collection to receive daily e-mail notification of new additions RSS Feed
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 146
 more >
PreviewIssue DateTitleContributor(s)
2018 TRJLCM Volume 196 June (7).pdf.jpg2018Original Articles 17 Maraviroc improves hepatic triglyceride content but not inflammation in a murine nonalcoholic fatty liver disease model induced by a chronic exposure to high-fat diet-
2018 TRJLCM Volume 196 June (6).pdf.jpg2018Treatment of acetaminophen-induced liver injury with exogenous mitochondria in miceShi, X
TRJLCM 2018 Volume 200 October (12).pdf.jpg2018Featured New Investigator VOLUME 200 , OCTOBER 2018 MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species Vaccination with a CD4 + and CD8 + T-cell epitopes-based recomVera-puente, Olga; Rodriguez-antolin, Carlos; Salgado-figueroa, Ana; Michalska, Patrycja; Jimenez, Julia; Pernia, Olga; Reid, Brett M; Garcia-guede, Alvaro; Sacrist, Silvia; Esteban-rodriguez, Isabel; Martin, M Elena; Sellers, Thomas A; Leo, Rafael; Gonzalez, M; Dias,
TRJLCM 2018 Volume 200 October (8).pdf.jpg2018Featured New Investigator VOLUME 200 , OCTOBER 2018 MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species Vaccination with a CD4 + and CD8 + T-cell epitopes-based recomVera-puente, Olga; Rodriguez-antolin, Carlos; Salgado-figueroa, Ana; Michalska, Patrycja; Jimenez, Julia; Pernia, Olga; Reid, Brett M; Garcia-guede, Alvaro; Sacrist, Silvia; Esteban-rodriguez, Isabel; Martin, M Elena; Sellers, Thomas A; Leo, Rafael; Gonzalez, M; Dias,
TRJLCM 2018 Volume 200 October (7).pdf.jpg2018MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen speciesOlga, D X; Olga, D X X; Brett, D X X; X, D X; Reid, M; Roc, D X X; Silvia, D X X; Jimenez, D X X Julia; Martin, D X X Elena; Sellers, A; Rafael, D X X
TRJLCM 2018 Volume 200 October (6).pdf.jpg2018Histone deacetylase inhibition attenuates atrial arrhythmogenesis in sterile pericarditisChang, Chien-jung; Li, Shao-jung; Chen, Yao-chang; Huang, Shih-yu; Chen, Shih-ann; Chen, Yi-jen
TRJLCM 2018 Volume 200 October (5).pdf.jpg2018Plasminogen activator inhibitor-1 is associated with the metabolism and development of advanced colonic polypsChen, Tsung-hsing; Hsu, Chen-ming; Hsu, Hung-chih; Chiu, Cheng-tang
TRJLCM 2018 Volume 200 October (4).pdf.jpg2018Response to aspirin therapy in patients with myeloproliferative neoplasms depends on the platelet countThomas, D X; Dx, Gremmel; Dx, Gisslinger
TRJLCM 2018 Volume 201 November (1).pdf.jpg2018Circulating tumor cells as “liquid biopsies” to understand cancer metastasisWoo, Dennis; Yu, M I N
TRJLCM 2018 Volume 200 October (3).pdf.jpg2018The assessment of multipotent cellJuan, D X X
TRJLCM 2018 Volume 199 September (8).pdf.jpg2018Translational researchLaurence, Jeffrey
TRJLCM 2018 Volume 200 October (9).pdf.jpg2018Translational researchLaurence, Jeffrey
TRJLCM 2018 Volume 198 August (13).pdf.jpg2018In-Depth Review on Proteasome Biology and Therapeutics Review Article Next-generation proteasome inhibitors for cancer therapy VOLUME 198 , AUGUST 2018 The ubiquitin proteasome system as a potential therapeutic target for systemic sclerosis Ubiquitin-protPark, Ji Eun; Miller, Zachary; Jun, Yearin; Lee, Wooin; Kim, Kyung Bo; Korea, Republic
TRJLCM 2018 Volume 199 September (1).pdf.jpg2018Prophylactic and therapeutic activity of alkaline phosphatase in arthritic rats : single-agent effects of alkaline phosphatase and synergistic effects in combination with methotrexateDurga, D X; Carla, D X X; Wayne, D X X; Philip, D X X; Low, S; Anthony, D X; Albert, D X X
TRJLCM 2018 Volume 198 August (4).pdf.jpg2018Next-generation proteasome inhibitors for cancer therapyPark, J I E U N; Miller, Zachary; Jun, Yearin; Lee, Wooin; Kim, Kyung B O
TRJLCM 2018 Volume 198 August (9).pdf.jpg2018Aim for the core: suitability of the ubiquitin-independent 20S proteasome as a drug target in neurodegenerationOpoku-nsiah, Kwadwo A; Gestwicki, Jason E
TRJLCM 2018 Volume 198 August (5).pdf.jpg2018The ubiquitin proteasome system as a potential therapeutic target for systemic sclerosisMeiners, Silke; Evankovich, John; Mallampalli, Rama K
TRJLCM 2018 Volume 198 August (11).pdf.jpg2018Translational researchBecker, Bryan Neil; Beer, David G; Davidson, Nicholas O
TRJLCM 2018 Volume 198 August (3).pdf.jpg2018Editorial Scope and PolicyLaurence, Jeffrey; Street, East; York, New
TRJLCM 2018 Volume 198 August (10).pdf.jpg2018Translational researchLaurence, Jeffrey
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 146
 more >